Literature DB >> 19453941

HDL-cholesterol and future risk of venous thromboembolism: the Tromsø Study.

S K Braekkan, K H Borch, E B Mathiesen, I Njølstad, J B Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19453941     DOI： 10.1111/j.1538-7836.2009.03481.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Extrahepatic high-density lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice.

Authors:  Alexander Brill; Ayce Yesilaltay; Simon F De Meyer; Janka Kisucka; Tobias A Fuchs; Olivier Kocher; Monty Krieger; Denisa D Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-31       Impact factor: 8.311

2.  Effect of anti-ApoA-I antibody-coating of stents on neointima formation in a rabbit balloon-injury model.

Authors:  Aart C Strang; Menno L W Knetsch; Leo H Koole; Robbert J de Winter; Allard C van der Wal; Carlie J M de Vries; Paul P Tak; Radjesh J Bisoendial; Erik S G Stroes; Joris I Rotmans
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

3.  High Low-Density Lipoprotein Cholesterol Inversely Relates to Dementia in Community-Dwelling Older Adults: The Shanghai Aging Study.

Authors:  Fen Zhou; Wei Deng; Ding Ding; Qianhua Zhao; Xiaoniu Liang; Fei Wang; Jianfeng Luo; Li Zheng; Qihao Guo; Zhen Hong
Journal:  Front Neurol       Date:  2018-11-12       Impact factor: 4.003

Review 4.  Immune Factors in Deep Vein Thrombosis Initiation.

Authors:  Ivan Budnik; Alexander Brill
Journal:  Trends Immunol       Date:  2018-05-16       Impact factor: 16.687
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.